gasguide

Sevoflurane

Ultane · Sevorane

Halogenated methyl isopropyl ether — volatile general anesthetic

Multi-site CNS depression: GABA-A potentiation, glycine receptor potentiation, NMDA + nicotinic ACh inhibition, two-pore K⁺ channel activation. Net: dose-dependent unconsciousness, amnesia, immobility, and analgesia (modest).

Indications

  • GA induction (mask, especially pediatric)
  • GA maintenance
  • Bronchospasm rescue (volatile bronchodilation)

Dosing

ContextAdultPediatric
Mask induction (peds)Up to 8% inspired with O₂ ± N₂O; titrate down post-LOC8% inspired (single-breath or stepwise) — tolerated due to non-pungent character
Adult induction (slow)Stepwise 1→8% over several breaths; bridge to IV induction more common in adults
Maintenance0.5–2.5% inspired (1 MAC ≈ 2.05% age 40; declines ~6%/decade)MAC age 6 mo–1 y ≈ 3.2%; MAC neonate ≈ 3.3%; declines through childhood

Pharmacokinetics

Blood:gas partition coefficient 0.65 (low → fast on/off). MAC 2.05% age 40, drops ~6% per decade. Minimally metabolized (~5% by CYP2E1 to inorganic fluoride + hexafluoroisopropanol). Standard wash-in/wash-out within minutes.

Hemodynamic effects

Dose-dependent ↓SVR + ↓MAP (mild–moderate). Cardiac output relatively preserved vs other volatiles. Minimal coronary vasodilation (no clinically significant 'coronary steal'). HR usually stable; can rise mildly at >1.5 MAC.

Respiratory effects

Non-pungent — gold standard for pediatric mask induction. Dose-dependent ↓TV and ↑RR (rapid shallow). Bronchodilator. Blunts hypoxic + hypercarbic ventilatory drive.

Side effects

  • !Compound A formation in CO₂ absorbents (esp. desiccated soda lime with NaOH/KOH bases) — theoretical nephrotoxicity at FGF <1 L/min × prolonged exposure; modern Amsorb-class absorbents eliminate. Clinical relevance in humans remains unproven.
  • !Emergence delirium in pediatric patients (20–80% incidence; mitigate with dexmedetomidine 0.3 mcg/kg, propofol 1 mg/kg at end, or fentanyl)
  • !MH trigger (all halogenated agents are)
  • !Postoperative shivering (volatile-class effect)
  • !Mild hepatotoxicity (rare; lower than des/iso/halothane)

Contraindications

  • ×MH susceptibility (any volatile)
  • ×Severe hepatic dysfunction (relative)
  • ×Pheochromocytoma (relative — sympathetic stim with high-dose volatiles)

Clinical pearls

  • FAST induction + FAST emergence: blood:gas 0.65 means changes in inspired concentration reach effect-site within 1–2 min.
  • Pediatric induction of choice — non-pungent, no breath-holding, no laryngospasm trigger like desflurane.
  • MAC additive with N₂O: 1 MAC sevo (2.05%) + 50% N₂O (≈ 0.48 MAC) = ~1.48 MAC total.
  • Compound A is essentially a non-issue with modern (Amsorb-class) absorbents and FGF >1 L/min.
  • Avoid for 'awake-craniotomy asleep phases' — emergence delirium worse than propofol TIVA.
Education only — confirm against current package inserts and institutional protocols. Doses assume normal organ function unless otherwise noted.